Julio Osorio, PhD | Viral Oncology (HPV/EBV)

Oncovirology (HPV/EBV) | PhD Biomedicine | Translational cancer biology (PCR/IHC/CISH, cell models) | 750+ cites (h=17) | DM for collabs/seminars

[Julio Osorio, PhD | Viral Oncology (HPV/EBV) @Juliogen]

🦠 Un virus puede infectarte hoy.

🎗️ El cáncer podría aparecer décadas después.
¿Por qué millones de personas se infectan y sólo unas pocas desarrollan cáncer?
Más información: https://t.co/HvQkPkBUf0

[Julio Osorio, PhD | Viral Oncology (HPV/EBV) @Juliogen]

Tras años investigando cómo virus como VPH y Epstein-Barr participan en el cáncer, lancé el Centro de Medicina de Precisión y Genómica Aplicada. 🧬 Investigación, oncogenómica, cursos gratuitos y educación en salud. 👉 https://t.co/piNkep36U5 #Genómica #VPH

[Julio Osorio, PhD | Viral Oncology (HPV/EBV) @Juliogen]

Meta-análisis: 14% OPSCC vs 10% OSCC (IC95%) Colombia 31% HPV oral. #CienciaLatina #VPH ¿Screening VPH oral Colombia?

[Julio Osorio, PhD | Viral Oncology (HPV/EBV) @Juliogen]

1/3 🔥 OPSCC 3X coinfección EBV+HPV vs OSCC!

[Julio Osorio, PhD | Viral Oncology (HPV/EBV) @Juliogen]

1/3 🔥 OPSCC 3X coinfección EBV+HPV vs OSCC!

[Comunidad Biológica @Bio_comunidad]

Estamos viendo un bacteriófago: un virus que infecta bacterias. Se adhiere a la célula, inyecta su ADN y la convierte en una fábrica de nuevos virus hasta que finalmente la bacteria se rompe.

[Julio Osorio, PhD | Viral Oncology (HPV/EBV) @Juliogen]

“Paper (2026) DOI: https://t.co/iYgoWpi5kD”

[Julio Osorio, PhD | Viral Oncology (HPV/EBV) @Juliogen]

Reply “PDF” and I’ll share the paper + a 1-page summary.
If you run breast cancer cohorts or tissue workflows, let’s compare best-practice controls.

[Julio Osorio, PhD | Viral Oncology (HPV/EBV) @Juliogen]

Reply “PDF” and I’ll share the paper + a 1-page summary.
If you run breast cancer cohorts or tissue workflows, let’s compare best-practice controls.

[Julio Osorio, PhD | Viral Oncology (HPV/EBV) @Juliogen]

If a true virus-associated subset exists, it could reshape prevention + biomarkers—but only with reproducible, contamination-proof methods.

[Julio Osorio, PhD | Viral Oncology (HPV/EBV) @Juliogen]

Causality checklist:

Multi-target detection + strict contamination controls

Tumor-cell localization (ISH/IHC)

Independent replication

Infection precedes disease

Mechanistic plausibility

[Julio Osorio, PhD | Viral Oncology (HPV/EBV) @Juliogen]

MMTV-like viruses in human breast cancer: causality or contamination?
In our 2026 review we propose a causality framework.
What would convince you most: (A) tumor-cell localization, (B) integration/replication evidence, or (C) infection-before-cancer cohorts?

[Julio Osorio, PhD | Viral Oncology (HPV/EBV) @Juliogen]

https://t.co/FjyQNQzqmt

[Julio Osorio, PhD | Viral Oncology (HPV/EBV) @Juliogen]

Here, we synthesize the evidence through a causality-oriented framework that integrates (i) standardized multi-target detection with mandatory contamination controls, (ii) epidemiologic designs https://t.co/JRUfHTVkK8

[Dr. Javier Flores @farmacotips]

Marcadores tumorales que debes recordar:

Tumor de ovario → CA 125
Tumor de mama → CA 15-3
Tumor pancreático → CA 19-9
Tumor de próstata → PSA
Tumor colorrectal → CEA
Teratoma → AFP
Seminoma → LDH
Coriocarcinoma → Beta-hCG
Células pequeñas (CPCP) → NSE
Gastrinoma → Gastrina

[Julio Osorio, PhD | Viral Oncology (HPV/EBV) @Juliogen]

This study investigated the presence of human papillomavirus (HPV) in lung cancer patients from Chile. We found that HPV is present in 4% of lung carcinomas and that the SLC7A11/xCT gene is frequently up-regulated in HPV-positive lung carcinomas. https://t.co/A5XoNqEfrG

[Julio Osorio, PhD | Viral Oncology (HPV/EBV) @Juliogen]

Congreso SoMiCh Chile. Ponencia oral "Barf1 in lung cancer anthracosis"

[Julio Osorio, PhD | Viral Oncology (HPV/EBV) @Juliogen]

https://t.co/7HzJ7EggB1

[Julio Osorio, PhD | Viral Oncology (HPV/EBV) @Juliogen]

https://t.co/SXD7RXcA3p